The Food and Drugs Authority (FDA) has approved 2 additional COVID-19 vaccines for importation, distribution, and use in Ghana.
The two new vaccines are Moderna (Spikevax) and Pfizer-BioNTech (Comirnaty) bringing the total number of approved COVID-19 vaccines for use in Ghana to 5.
The statement from the FDA reads in parts “the Emergency Use Authorization (EUA) pathway, which is the accepted procedure for all national regulatory authorities globally, to ensure timely access to quality and safe medical products including vaccines during this pandemic.”
The Authority assured the public that all the approved COVID-19 vaccines have been subjected to rigorous safety parameters and urged them to receive the vaccines without any reservations.
“The FDA remains committed to safeguarding the health and safety of the public as mandated by the Public Health Act, 2012 (Act 851),” the statement added.
Below is the statement from the FDA
Source: A1Radioonline.com/ 101.1MHz/ Ghana
